VEGFC and urinary bladder neoplasm: In addition, present data also indicate that the suppression of VEGF-C/D signaling by adenoviral delivery of sVR3 significantly reduced the growth of lymphatic vessels in bladder tumor and SLN and eventually inhibited lymphatic metastasis of bladder tumor cells from primary tumor to SLN without significant reductions of tumor mass and blood vessels in OUBC.